| ²é¿´: 1152 | »Ø¸´: 7 | |||||||||||||||
jennifer9707гæ (³õÈëÎÄ̳)
|
[½»Á÷]
ÒºÌåÖÆ¼Á¿ÆÑ§¼Ò£¨´ó·Ö×ӺϳɾÑ飩
|
ÒºÌåÖÆ¼Á¿ÆÑ§¼Ò ÔÚѧУ»ò¹¤×÷ÖÐÓдó·Ö×ӺϳɾÑ飻 ѧÀú£ºË¶Ê¿±ØÐë3ÄêÒÔÉϹ¤×÷¾Ñ飻²©Ê¿¿ÉÒÔÎÞ¹¤×÷¾ÑéµÄ±ÏÒµÉú£» ÓïÑÔ£ºÓ¢ÎÄÌý˵¶ÁдÊìÁ· |
» ²ÂÄãϲ»¶
[¸´ÊÔµ÷¼Á]Î÷ÄϿƼ¼´óѧ¹ú·À/²ÄÁϵ¼Ê¦ÍƼö
ÒѾÓÐ6È˻ظ´
»¯Ñ§¹¤³Ì321·ÖÇóµ÷¼Á
ÒѾÓÐ12È˻ظ´
211±¾£¬11408Ò»Ö¾Ô¸ÖпÆÔº277·Ö£¬ÔøÔÚÖпÆÔº×Ô¶¯»¯Ëùʵϰ
ÒѾÓÐ4È˻ظ´
²ÄÁÏר˶326Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
¶«ÄÏ´óѧ364Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
¹ú×Ô¿ÆÃæÉÏ»ù½ð×ÖÌå
ÒѾÓÐ7È˻ظ´
ҩѧ383 Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
286Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
085601Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
302Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
¹ý³Ì¹¤³ÌËù2011ÄêÕÐÆ¸ÆôÊÂ
ÒѾÓÐ9È˻ظ´
ÖæÀ¶
Ìú³æ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 213.4
- ºì»¨: 1
- Ìû×Ó: 22
- ÔÚÏß: 13.4Сʱ
- ³æºÅ: 1432251
- ×¢²á: 2011-10-08
- ÐÔ±ð: GG
- רҵ: ÓлúºÏ³É
2Â¥2013-08-13 23:36:25
zhengyi
ľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 3917.5
- É¢½ð: 219
- ºì»¨: 2
- Ìû×Ó: 1894
- ÔÚÏß: 745.2Сʱ
- ³æºÅ: 138089
- ×¢²á: 2005-12-18
- רҵ: »¯Ñ§ÉúÎïѧÓëÉúÎïÓлú»¯Ñ§

3Â¥2013-08-14 08:04:52
xiaoyuerxiao
ľ³æ (ÖøÃûдÊÖ)
Îå
- Ó¦Öú: 11 (СѧÉú)
- ½ð±Ò: 1947.5
- É¢½ð: 15
- ºì»¨: 9
- Ìû×Ó: 1203
- ÔÚÏß: 621.7Сʱ
- ³æºÅ: 920940
- ×¢²á: 2009-12-05
- ÐÔ±ð: GG
- רҵ: ºÏ³ÉÒ©Îﻯѧ

4Â¥2013-08-14 09:17:07
jennifer9707
гæ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 51.5
- Ìû×Ó: 48
- ÔÚÏß: 14.6Сʱ
- ³æºÅ: 2499502
- ×¢²á: 2013-06-07
- רҵ: Ò©Îï´úлÓëÒ©ÎﶯÁ¦Ñ§
|
Responsible for the development and characterization of parenteral formulations, with the emphasize on biologics in the Centre of Pharmaceutical Sciences under the Discovery Center of China R&D and SA. The incumbent is expected to manage the operation of the formulation lab and to conduct the formulation activities for various parenteral dosage forms, such as liquid, lyo, suspensions, microspheres and nano-crystals. He/she is also expected to work closely with the manufacturing facilities in China to ensure the timely and smooth scale up and technical transfer. The incumbent will facilitate the verification of noval formulations and processes in a due-diligent team. The incumbent is responsible for the design, conduction, supervision, and reporting of studies that are carried out internally and in contract labs. He/she is responsible for the ensuring compliance and integrity of the studies. • Develop liquid, lyophilized, micronized, and nano and sustained release parenteral formulations of large and small molecules. • Preformulation characterization of new formulations using various lab instruments (e.g. HPLC, CE, UV, DSC, ITC, CD, DLS/SLS, Zeta, Rheometer, etc.). • Provide data and justification for NCE declaration, CTA, BLA and NDA submissions for filing in China. • Formulate stable dosage forms consistent with preclinical and clinical needs. • Evaluate new excipients or platforms to modify solubility and/or stability. • Identify and analyze degradation products and possible degradation mechanisms in formulations. • Write technical reports and present scientific results at internal and external meetings. • Coordinate the work of technical personnel with a special regard to accuracy and reliability of their data. • Ensure the adherence to SOPs and policies. • Train and/or provide work direction to research associates and interns. • Maintain and enforce safety regulations and cleanliness in the work area • Work closely with the manufacturing facilities in China to ensure the timely and smooth scale up and technical transfer Qualifications • Candidate must be a BS with 5+ years, M.S. with 2+ years or a Ph.D with 0+ years of industrial experience in Biochemistry, Engineer, Chemistry, Pharmaceutics or one of the related disciplines • The candidate must be willing and able to work in a laboratory environment • Detail-oriented • Good problem solving capability • Experience in working in a Chinese-speaking country is required. • Strong oral and written communication skills • Good planning and tracking skills |
5Â¥2013-08-14 09:20:50
jennifer9707
гæ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 51.5
- Ìû×Ó: 48
- ÔÚÏß: 14.6Сʱ
- ³æºÅ: 2499502
- ×¢²á: 2013-06-07
- רҵ: Ò©Îï´úлÓëÒ©ÎﶯÁ¦Ñ§
6Â¥2013-08-14 09:21:54
jennifer9707
гæ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 51.5
- Ìû×Ó: 48
- ÔÚÏß: 14.6Сʱ
- ³æºÅ: 2499502
- ×¢²á: 2013-06-07
- רҵ: Ò©Îï´úлÓëÒ©ÎﶯÁ¦Ñ§
7Â¥2013-08-14 09:35:42

8Â¥2013-10-22 15:20:29













»Ø¸´´ËÂ¥